Cryolife announces sale of perclot to baxter

Atlanta, july 29, 2021 /prnewswire/ -- cryolife, inc. (nyse: cry), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale of its perclot product line to a subsidiary of baxter international, inc. ("baxter") (nyse: bax ), for up to $60.8 million in cash. of the $60.8 million, cryolife will receive up to $45.8 million and starch medical, inc. ("smi") will receive up to $15.0 million.
BAX Ratings Summary
BAX Quant Ranking